Loading…

First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria

The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2014-09, Vol.33 (9), p.1641-1646
Main Authors: Agabou, A., Pantel, A., Ouchenane, Z., Lezzar, N., Khemissi, S., Satta, D., Sotto, A., Lavigne, J.-P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303
cites cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303
container_end_page 1646
container_issue 9
container_start_page 1641
container_title European journal of clinical microbiology & infectious diseases
container_volume 33
creator Agabou, A.
Pantel, A.
Ouchenane, Z.
Lezzar, N.
Khemissi, S.
Satta, D.
Sotto, A.
Lavigne, J.-P.
description The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period from patients presenting E. coli infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance, bla genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated E. coli , 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a bla OXA-48 and was identified as a B1 ST5 strain. The transposon bearing this gene was Tn 1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of bla CTX-M-15 , which was coupled with qnr genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing E. coli and the emergence of the intercontinental ST131 bla CTX-15 -producing E. coli strains in Algeria.
doi_str_mv 10.1007/s10096-014-2122-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1560136233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1553104361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</originalsourceid><addsrcrecordid>eNqNkc-KFDEQxoMo7rj6AF4kIIKXaCpJ589xWHZVWNiDK3hrMulkJ0t3Mibdh3mLfWQzzLiKIHhJQtXvq0rVh9BroB-AUvWxttNIQkEQBoyR_RO0AsE7IrjiT9GKGi6IUYyfoRe13tOm0Uo9R2dMKNMUeoUermKpMx58dSXu5pgTzgHffF8Tocmu5GFxMd3hy-q2vkS3jRa7PEZs04Dnrce79vBTdNiNOXn89RY44FDy1DJz9GmueJvrLs52jNUP2M7Y4imOLVD2jykcE16Pd62DfYmeBTtW_-p0n6NvV5e3F5_J9c2nLxfra-I6gJnwoMEo4T1o00k9dG7DJRNhoIoNjnsDminYqBCClT5It9FKaOupMFIKTvk5en-s24b8sfg691Oszo-jTT4vtYdOUmglOf8PtONABZfQ0Ld_ofd5KakNcqBY1xluDhQcKVdyrcWHflfi1BbSA-0PzvZHZ_vmbH9wtt83zZtT5WUz-eFR8cvKBrw7AbY6O4Zik4v1N6cVAMiucezI1ZZKbed_fPGf3X8Cnc66vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552559391</pqid></control><display><type>article</type><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><source>Springer Link</source><creator>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</creator><creatorcontrib>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</creatorcontrib><description>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period from patients presenting E. coli infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance, bla genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated E. coli , 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a bla OXA-48 and was identified as a B1 ST5 strain. The transposon bearing this gene was Tn 1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of bla CTX-M-15 , which was coupled with qnr genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing E. coli and the emergence of the intercontinental ST131 bla CTX-15 -producing E. coli strains in Algeria.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-014-2122-y</identifier><identifier>PMID: 24792128</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adolescent ; Adult ; Aged ; Algeria ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; beta-Lactamases - genetics ; beta-Lactamases - secretion ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Child ; Child, Preschool ; Cloning ; DNA Transposable Elements ; Drug Resistance, Multiple, Bacterial ; E coli ; Enzymes ; Escherichia coli ; Escherichia coli - classification ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Escherichia coli - isolation &amp; purification ; Escherichia coli Infections - microbiology ; Female ; Genes ; Genotype ; Hospitals, Military ; Humans ; Infant ; Infections ; Infectious diseases ; Internal Medicine ; Male ; Medical Microbiology ; Medical sciences ; Microbial Sensitivity Tests ; Middle Aged ; Molecular Typing ; Pandemics ; Patients ; Phylogenetics ; Phylogeny ; Polymerase chain reaction ; Serotyping ; Young Adult</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2014-09, Vol.33 (9), p.1641-1646</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</citedby><cites>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28711165$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24792128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agabou, A.</creatorcontrib><creatorcontrib>Pantel, A.</creatorcontrib><creatorcontrib>Ouchenane, Z.</creatorcontrib><creatorcontrib>Lezzar, N.</creatorcontrib><creatorcontrib>Khemissi, S.</creatorcontrib><creatorcontrib>Satta, D.</creatorcontrib><creatorcontrib>Sotto, A.</creatorcontrib><creatorcontrib>Lavigne, J.-P.</creatorcontrib><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period from patients presenting E. coli infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance, bla genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated E. coli , 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a bla OXA-48 and was identified as a B1 ST5 strain. The transposon bearing this gene was Tn 1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of bla CTX-M-15 , which was coupled with qnr genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing E. coli and the emergence of the intercontinental ST131 bla CTX-15 -producing E. coli strains in Algeria.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Algeria</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>beta-Lactamases - genetics</subject><subject>beta-Lactamases - secretion</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cloning</subject><subject>DNA Transposable Elements</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>E coli</subject><subject>Enzymes</subject><subject>Escherichia coli</subject><subject>Escherichia coli - classification</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - isolation &amp; purification</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Female</subject><subject>Genes</subject><subject>Genotype</subject><subject>Hospitals, Military</subject><subject>Humans</subject><subject>Infant</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical Microbiology</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Molecular Typing</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Polymerase chain reaction</subject><subject>Serotyping</subject><subject>Young Adult</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkc-KFDEQxoMo7rj6AF4kIIKXaCpJ589xWHZVWNiDK3hrMulkJ0t3Mibdh3mLfWQzzLiKIHhJQtXvq0rVh9BroB-AUvWxttNIQkEQBoyR_RO0AsE7IrjiT9GKGi6IUYyfoRe13tOm0Uo9R2dMKNMUeoUermKpMx58dSXu5pgTzgHffF8Tocmu5GFxMd3hy-q2vkS3jRa7PEZs04Dnrce79vBTdNiNOXn89RY44FDy1DJz9GmueJvrLs52jNUP2M7Y4imOLVD2jykcE16Pd62DfYmeBTtW_-p0n6NvV5e3F5_J9c2nLxfra-I6gJnwoMEo4T1o00k9dG7DJRNhoIoNjnsDminYqBCClT5It9FKaOupMFIKTvk5en-s24b8sfg691Oszo-jTT4vtYdOUmglOf8PtONABZfQ0Ld_ofd5KakNcqBY1xluDhQcKVdyrcWHflfi1BbSA-0PzvZHZ_vmbH9wtt83zZtT5WUz-eFR8cvKBrw7AbY6O4Zik4v1N6cVAMiucezI1ZZKbed_fPGf3X8Cnc66vw</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Agabou, A.</creator><creator>Pantel, A.</creator><creator>Ouchenane, Z.</creator><creator>Lezzar, N.</creator><creator>Khemissi, S.</creator><creator>Satta, D.</creator><creator>Sotto, A.</creator><creator>Lavigne, J.-P.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>7T2</scope><scope>7U2</scope></search><sort><creationdate>20140901</creationdate><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><author>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Algeria</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>beta-Lactamases - genetics</topic><topic>beta-Lactamases - secretion</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cloning</topic><topic>DNA Transposable Elements</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>E coli</topic><topic>Enzymes</topic><topic>Escherichia coli</topic><topic>Escherichia coli - classification</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - isolation &amp; purification</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Female</topic><topic>Genes</topic><topic>Genotype</topic><topic>Hospitals, Military</topic><topic>Humans</topic><topic>Infant</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical Microbiology</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Molecular Typing</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Polymerase chain reaction</topic><topic>Serotyping</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agabou, A.</creatorcontrib><creatorcontrib>Pantel, A.</creatorcontrib><creatorcontrib>Ouchenane, Z.</creatorcontrib><creatorcontrib>Lezzar, N.</creatorcontrib><creatorcontrib>Khemissi, S.</creatorcontrib><creatorcontrib>Satta, D.</creatorcontrib><creatorcontrib>Sotto, A.</creatorcontrib><creatorcontrib>Lavigne, J.-P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agabou, A.</au><au>Pantel, A.</au><au>Ouchenane, Z.</au><au>Lezzar, N.</au><au>Khemissi, S.</au><au>Satta, D.</au><au>Sotto, A.</au><au>Lavigne, J.-P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>33</volume><issue>9</issue><spage>1641</spage><epage>1646</epage><pages>1641-1646</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period from patients presenting E. coli infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance, bla genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated E. coli , 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a bla OXA-48 and was identified as a B1 ST5 strain. The transposon bearing this gene was Tn 1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of bla CTX-M-15 , which was coupled with qnr genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing E. coli and the emergence of the intercontinental ST131 bla CTX-15 -producing E. coli strains in Algeria.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24792128</pmid><doi>10.1007/s10096-014-2122-y</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2014-09, Vol.33 (9), p.1641-1646
issn 0934-9723
1435-4373
language eng
recordid cdi_proquest_miscellaneous_1560136233
source Springer Link
subjects Adolescent
Adult
Aged
Algeria
Anti-Bacterial Agents - pharmacology
Antibiotic resistance
Antibiotics
Antimicrobial agents
beta-Lactamases - genetics
beta-Lactamases - secretion
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Child
Child, Preschool
Cloning
DNA Transposable Elements
Drug Resistance, Multiple, Bacterial
E coli
Enzymes
Escherichia coli
Escherichia coli - classification
Escherichia coli - enzymology
Escherichia coli - genetics
Escherichia coli - isolation & purification
Escherichia coli Infections - microbiology
Female
Genes
Genotype
Hospitals, Military
Humans
Infant
Infections
Infectious diseases
Internal Medicine
Male
Medical Microbiology
Medical sciences
Microbial Sensitivity Tests
Middle Aged
Molecular Typing
Pandemics
Patients
Phylogenetics
Phylogeny
Polymerase chain reaction
Serotyping
Young Adult
title First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A30%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20description%20of%20OXA-48-producing%20Escherichia%20coli%20and%20the%20pandemic%20clone%20ST131%20from%20patients%20hospitalised%20at%20a%20military%20hospital%20in%20Algeria&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Agabou,%20A.&rft.date=2014-09-01&rft.volume=33&rft.issue=9&rft.spage=1641&rft.epage=1646&rft.pages=1641-1646&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-014-2122-y&rft_dat=%3Cproquest_cross%3E1553104361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552559391&rft_id=info:pmid/24792128&rfr_iscdi=true